Home
/
Instil Bio, Inc.
/
Financials
/
Quarterly
Instil Bio, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Instil Bio, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2021
Sep 30, 2021
$0
Nov 15, 2021
Q2
2021
Jun 30, 2021
$0
Aug 12, 2021
Q1
2021
Mar 31, 2021
$0
May 13, 2021
Q3
2021
Sep 30, 2020
$52.0K
Nov 15, 2021
Q2
2021
Jun 30, 2020
$42.0K
Aug 12, 2021
Q1
2021
Mar 31, 2020
$44.0K
May 13, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($13.59M)
Nov 13, 2025
Q3
2025
Jun 30, 2025
($21.39M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($21.39M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($28.20M)
May 13, 2025
Q3
2025
Mar 31, 2025
($28.20M)
Nov 13, 2025
Q2
2025
Mar 31, 2025
($28.20M)
Aug 13, 2025
Q3
2025
Sep 30, 2024
($23.02M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($14.92M)
Aug 13, 2025
Q3
2025
Jun 30, 2024
($14.92M)
Nov 13, 2025
Q2
2025
Mar 31, 2024
($24.30M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($24.30M)
May 13, 2025
Q3
2025
Mar 31, 2024
($24.30M)
Nov 13, 2025
Q3
2024
Sep 30, 2023
($67.43M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($18.66M)
Aug 13, 2024
Q3
2024
Jun 30, 2023
($18.66M)
Nov 13, 2024
Q1
2024
Mar 31, 2023
($57.07M)
May 10, 2024
Q3
2024
Mar 31, 2023
($57.07M)
Nov 13, 2024
Q2
2024
Mar 31, 2023
($57.07M)
Aug 13, 2024
Q3
2023
Sep 30, 2022
($56.22M)
Nov 13, 2023
Q3
2023
Jun 30, 2022
($58.99M)
Nov 13, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($15.02M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($23.44M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($30.56M)
May 13, 2025
Q3
2025
Sep 30, 2024
($23.63M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($14.14M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($23.96M)
May 13, 2025
Q3
2024
Sep 30, 2023
($66.72M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($20.99M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($58.45M)
May 10, 2024
Q3
2023
Sep 30, 2022
($56.65M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($58.72M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($54.29M)
May 11, 2023
Q3
2022
Sep 30, 2021
($43.02M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($35.38M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($23.40M)
May 16, 2022
Q3
2021
Sep 30, 2020
($7.71M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($4.59M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($3.86M)
May 13, 2021